Go to content
To the homepage of National Health Care Institute
National Health Care Institute
Home
Publications
Enter what you are looking for
Eltrombopag (Revolade) for the indication 'Immune (idiopathic) thrombocytopenic purpura'
This report is a summary of recommendations by Zorginstituut Nederland. The original text is in Dutch.
Download:
Eltrombopag (Revolade) for the indication 'Immune (idiopathic) thrombocytopenic purpura'
Report
23-08-2010
PDF document
89.3 KB